Back to Search Start Over

Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion.

Authors :
Panaro, Brandon L.
Yusta, Bernardo
Matthews, Dianne
Koehler, Jacqueline A.
Song, Youngmi
Sandoval, Darleen A.
Drucker, Daniel J.
Source :
Molecular Metabolism; Jul2020, Vol. 37, pN.PAG-N.PAG, 1p
Publication Year :
2020

Abstract

Glucagon-like peptide-1 is a nutrient-sensitive hormone secreted from enteroendocrine L cells within the small and large bowel. Although GLP-1 levels rise rapidly in response to food ingestion, the greatest density of L cells is localized to the distal small bowel and colon. Here, we assessed the importance of the distal gut in the acute L cell response to diverse secretagogues. Circulating levels of glucose and plasma GLP-1 were measured in response to the administration of L cell secretagogues in wild-type mice and in mice with (1) genetic reduction of Gcg expression throughout the small bowel and large bowel (Gcg <superscript>Gut−/-</superscript>) and (2) selective reduction of Gcg expression in the distal gut (Gcg <superscript>DistalGut−/-</superscript>). The acute GLP-1 response to olive oil or arginine administration was markedly diminished in Gcg <superscript>Gut−/-</superscript> but preserved in Gcg <superscript>DistalGut−/-</superscript> mice. In contrast, the increase in plasma GLP-1 levels following the administration of the GPR119 agonist AR231453, or the melanocortin-4 receptor (MC4R) agonist LY2112688, was markedly diminished in the Gcg <superscript>DistalGut−/-</superscript> mice. The GLP-1 response to LPS was also markedly attenuated in the Gcg <superscript>Gut−/-</superscript> mice and remained submaximal in the Gcg <superscript>DistalGut−/-</superscript> mice. Doses of metformin sufficient to lower glucose and increase GLP-1 levels in the Gcg <superscript>Gut+/+</superscript> mice retained their glucoregulatory activity, yet they failed to increase GLP-1 levels in the Gcg <superscript>Gut−/-</superscript> mice. Surprisingly, the actions of metformin to increase plasma GLP-1 levels were substantially attenuated in the Gcg <superscript>DistalGut−/-</superscript> mice. These findings further establish the importance of the proximal gut for the acute response to nutrient-related GLP-1 secretagogues. In contrast, we identify essential contributions of the distal gut to (i) the rapid induction of circulating GLP-1 levels in response to pharmacological selective agonism of G-protein-coupled receptors, (ii) the increased GLP-1 levels following the activation of Toll-Like Receptors with LPS, and iii) the acute GLP-1 response to metformin. Collectively, these results reveal that distal gut Gcg + endocrine cells are rapid responders to structurally and functionally diverse GLP-1 secretagogues. Image 1 • Distal gut Gcg expression is dispensable for GLP-1 response to olive oil and arginine. • GLP-1 response to GPR119 and MCR4 agonism requires distal gut Gcg expression. • The maximal GLP-1 response to lipopolysaccharide requires distal gut Gcg expression. • The distal gut is a substantial source of GLP-1 release in response to metformin. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22128778
Volume :
37
Database :
Supplemental Index
Journal :
Molecular Metabolism
Publication Type :
Academic Journal
Accession number :
143682477
Full Text :
https://doi.org/10.1016/j.molmet.2020.100990